Action INO INOVIO PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Inovio Pharmaceuticals, Inc.

Actions

INO

US45773H4092

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 21/06/2024 		Varia. 5j. Varia. 1 janv.
8,09 USD +0,25% Graphique intraday de Inovio Pharmaceuticals, Inc. -11,00% +32,19%
14/05 INOVIO PHARMACEUTICALS, INC. : Opinion positive de Stephens Inc. ZM
13/05 Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
PR
INOVIO Reports Inducement Grants Under Inducement Plan
PR
Inovio: Q1 Earnings Snapshot
AQ
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
PR
INOVIO Reports Inducement Grants Under Inducement Plan
PR
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
PR
INOVIO to Participate in Upcoming Investor Conferences in May
PR
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
PR
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
PR
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
AQ
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
PR
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PR
INOVIO Reports Inducement Grant Under Inducement Plan
PR
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
PR
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
PR
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
PR
Inovio: Q3 Earnings Snapshot
AQ
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
PR
INOVIO Reports Inducement Grants Under Inducement Plan
PR
INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action INO
  4. Actualités Inovio Pharmaceuticals, Inc.
  5. Communiqués